RANK Ligand Inhibitor [EPC] - N0000187055

Pharmacologic Code	N0000187055
Pharmacologic Name	RANK Ligand Inhibitor
Pharmacologic Uses	RANK ligand (RANKL) inhibitor
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 9 products whose active ingredient are classified under the same pharmacologic class RANK Ligand Inhibitor [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	55513-710	Prolia	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Amgen, Inc	ACTIVE
	55513-730	Xgeva	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Amgen, Inc	ACTIVE
	61314-228	Wyost	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Sandoz Inc	ACTIVE
	61314-240	Jubbonti	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Sandoz Inc	ACTIVE
	65219-668	Conexxence	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
	65219-670	Bomyntra	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
	65219-672	Bomyntra	Non-Proprietary Name: Denosumab	Injection	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
	72606-037	Stoboclo	Non-Proprietary Name: Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
	72606-038	Osenvelt	Non-Proprietary Name: Denosumab-bmwo	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE